esmolol has been researched along with enoximone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Boldt, J; Dapper, F; Hempelmann, G; Kling, D; Zickmann, B | 1 |
| Boldt, J; Brosch, C; Isgro, F; Lehmann, A; Suttner, S | 1 |
| Boldt, J; Suttner, S | 1 |
| Boldt, J; Lang, K; Mayer, J; Piper, SN; Röhm, K; Suttner, S | 1 |
| Boldt, J; Lang, K; Mayer, J; Mengistu, A; Suttner, S | 1 |
1 review(s) available for esmolol and enoximone
| Article | Year |
|---|---|
Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone.
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Drug Therapy, Combination; Enoximone; Humans; Infusions, Intravenous; Phosphodiesterase Inhibitors; Propanolamines; Time Factors | 2007 |
3 trial(s) available for esmolol and enoximone
| Article | Year |
|---|---|
Haemodynamic effects of the phosphodiesterase inhibitor enoximone in comparison with dobutamine in esmolol-treated cardiac surgery patients.
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Dobutamine; Drug Interactions; Enoximone; Hemodynamics; Humans; Imidazoles; Middle Aged; Phosphodiesterase Inhibitors; Propanolamines; Random Allocation | 1990 |
The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Aged; Biomarkers; Blood Gas Analysis; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelium, Vascular; Enoximone; Female; Glutathione Transferase; Heart Rate; Hemodynamics; Humans; Inflammation; Kidney Function Tests; Male; Monitoring, Intraoperative; Myocardial Ischemia; Phosphodiesterase Inhibitors; Postoperative Complications; Propanolamines; Splanchnic Circulation | 2004 |
Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients.
Topics: Adrenergic beta-Antagonists; Aged; Aorta, Abdominal; Cardiac Output; Cardiotonic Agents; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Humans; Intraoperative Complications; Male; Middle Aged; Myocardial Ischemia; Perioperative Care; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Postoperative Complications; Propanolamines; Prospective Studies; Single-Blind Method | 2009 |
2 other study(ies) available for esmolol and enoximone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Continuous beta-block with esmolol in combination with enoximone: influence on cardiac function in high risk patients undergoing vascular surgery].
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Atrial Natriuretic Factor; Cardiotonic Agents; Coronary Artery Disease; Drug Therapy, Combination; Electrocardiography; Enoximone; Female; Heart; Heart Function Tests; Heart Rate; Humans; Male; Middle Aged; Monitoring, Intraoperative; Phosphodiesterase Inhibitors; Propanolamines; Risk; Troponin T; Vascular Surgical Procedures | 2008 |